New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2014
10:33 EDTIRDM, HSOL, LGND, WSM, SEASHigh option volume stocks: IRDM HSOL LGND WSM SEAS
News For IRDM;HSOL;LGND;WSM;SEAS From The Last 14 Days
Check below for free stories on IRDM;HSOL;LGND;WSM;SEAS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 27, 2014
16:16 EDTWSMWilliams-Sonoma sees FY14 EPS $3.07-$3.17, consensus $3.20
Sees FY14 revenue $4.645B-$4.725B, consensus $4.72B. Sees FY14 comparable brand revenue growth of 5%-7%. Sees FY14 capital spending $200M-$220M.
16:14 EDTWSMWilliams-Sonoma sees Q3 EPS 58c-63c, consensus 66c
Subscribe for More Information
16:13 EDTWSMWilliams-Sonoma reports Q2 EPS 53c, consensus 53c
Subscribe for More Information
15:27 EDTWSMNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Workday (WDAY), consensus (14c); Williams-Sonoma (WSM), consensus 53c; Bally Technologies (BYI), consensus $1.22; Guess (GES), consensus 29c; Lannett (LCI), consensus 58c; Greif (GEF), consensus 84c.
14:54 EDTWSMWilliams-Sonoma technical comments ahead of earnings
In the prior three months the stock has outperformed the broader averages, trading up over 10.8%. The trend in the last three weeks has been strongly bullish after a more volatile trading range. Sentiment in the name is strongly bullish with the shares having hit a fresh 52-week high and life high earlier in Wednesday's session at $75.69. Without established overhead resistance, a target level above today's high would be at $80. On bearish news, a first test down of importance would be at the sell side analyst average 1-year price target of $71.16. A breakdown below that level on strongly disappointing news would be at $69.49.
08:03 EDTLGNDGlaxoSmithKline receives FDA approval for sNDA for Promacta/Revolade
Ligand Pharmaceuticals Incorporated (LGND) announced that its partner GlaxoSmithKline (GSK) has received approval of a supplemental New Drug Application for the once-daily use of Promacta/Revolade in patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. SAA is a blood disorder where the bone marrow fails to make enough red blood cells, white blood cells and platelets.2 Eltrombopag, an oral thrombopoietin receptor agonist, works by helping to induce proliferation and differentiation of bone marrow stem cells to increase production of blood cells.
07:25 EDTWSMWilliams-Sonoma September volatility elevated into Q2 and outlook
Subscribe for More Information
07:06 EDTIRDMIridium continues on track for its NEXT satellite
Iridium (IRDM) announced the successful upgrade of its System Control Segment and completion of its Launch and Early Operations control center for Iridium NEXT, the largest new commercial satellite constellation in the world. The overall development of the SCS is performed by Boeing (BA), which will continue operating the constellation through its transition to Iridium NEXT and beyond as the company's operations and maintenance provider.
August 26, 2014
07:56 EDTWSMWilliams-Sonoma deserves its valuation premium, says RW Baird
Baird believes Williams-Sonoma deserves a valuation premium given its superior multi-channel model, leverage to home related spending, and multiple avenues for growth. Shares of Williams-Sonoma are Outperform rated with a $73 price target, which the firm said will be revisited following the company's Q2 earnings report.
August 25, 2014
11:45 EDTLGNDLemelson says Ligand has 'lost favor with largest investors'
Subscribe for More Information
August 22, 2014
12:20 EDTSEASOn The Fly: Midday Wrap
Subscribe for More Information
10:19 EDTSEASSeaWorld jumps after analyst says animal concerns will abate
Subscribe for More Information
10:04 EDTSEASHigh option volume stocks: DYN SEAS FL ROST ZION
Subscribe for More Information
10:01 EDTSEASOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:00 EDTWSMWilliams-Sonoma September volatility elevated into Q2 and outlook
Williams-Sonoma September call option implied volatility is at 28, October is at 25, November is at 24; compared to its 26-week average of 25 according to Track Data, suggesting larger price movement into the expected release of Q2 results on August 27.
08:30 EDTSEASSeaWorld upgraded to Outperform from Market Perform at FBR Capital
Subscribe for More Information
07:49 EDTSEASSeaWorld upgraded to Outperform from Market Perform at FBR Capital
Subscribe for More Information
August 20, 2014
06:29 EDTSEASPETA buys more SeaWorld shares to be able to ask questions
Subscribe for More Information
06:00 EDTSEASStocks with implied volatility below IV index mean; SEAS WAG
Subscribe for More Information
August 19, 2014
06:01 EDTSEASStocks with implied volatility below IV index mean; SEAS WAG
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use